Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fischer Medical Ventures has informed that the Board of Directors of the Company vide resolution passed on March 26, 2025, approved the reconstitution of the Audit Committee, Nomination and Remuneration Committee, Stakeholder Relationship and Grievances Committee, Risk Management Committee and Corporate Social Responsibility Committee of the Board of Directors, effective from the conclusion of the Board Meeting held on March 26th 2025. Details of the aforesaid Committees are enclosed.
The above information is a part of company’s filings submitted to BSE.
